Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FAZ66
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,347
Award facts
- Contract value 100% obligated
- $11,346.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,346.78 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) pre-filled pens on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of delivery orders with the Defense Logistics Agency covering a wide spectrum of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's capability to fulfill federal requirements through open competition has resulted in consistent awards of firm fixed-price delivery orders with AmerisourceBergen serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This contract action for Ozempic, a diabetes medication, exemplifies the company's ongoing role in supporting military and veteran healthcare supply chains through the DLA's pharmaceutical procurement network.
Quick answers
Who was awarded contract SPE2DB25FAZ66?
SPE2DB25FAZ66 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FAZ66 worth?
The government has obligated $11,347 on SPE2DB25FAZ66.
Is contract SPE2DB25FAZ66 an order under another contract?
Yes. SPE2DB25FAZ66 is a delivery order under SPE2DB22D3009, an indefinite delivery contract.
Was contract SPE2DB25FAZ66 competed?
The extent of competition for SPE2DB25FAZ66 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award